Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma.

ABSTRACT:

SUBMITTER: Tai W 

PROVIDER: S-EPMC10166596 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature